
Tamoxifen is being evaluated in clinical trials as a preventive agent in women at high risk for breast cancer. This new, potentially long-term therapeutic role has generated some concerns regarding safety, based on the results of

Your AI-Trained Oncology Knowledge Connection!


Published: February 1st 1997 | Updated: